Cellnovo Group News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.02.18	Real-Life Retrospective Study Demonstrates Efficacy of Cellnovo’s Diabetes Management System (Businesswire)
17.01.18	Cellnovo Announces Its Q4 and Full Year 2017 Sales (Businesswire)
16.01.18	Cellnovo Announces Its 2018 Financial Calendar (Businesswire)
16.01.18	Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
08.01.18	Cellnovo Provides an Update on Manufacturing of Insulin Cartridges (Businesswire)
14.12.17	Cellnovo Announces the Launch of the First Clinical Study in the EU-Funded PEPPER Project That Uses Artificial Intelligence for the Management of Type 1 Diabetes (Businesswire)
13.12.17	Cellnovo Announces the CE Marking of the First Bluetooth® and Android™-Enabled Micro-Pump for Insulin Delivery (Businesswire)
08.12.17	Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
03.11.17	Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
03.11.17	Cellnovo Provides an Update on Its Partnership with Diabeloop for the Development of an Artificial Pancreas Solution (Businesswire)
25.10.17	Cellnovo Reports Q3 Sales and Cash Position at September 30, 2017 (Businesswire)
06.10.17	Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
25.09.17	Cellnovo Announces Its Half Year 2017 Results (Businesswire)
08.09.17	Cellnovo Provides Update on 510(k) Submission (Businesswire)
25.07.17	Cellnovo: 2017 First Half Sales (Businesswire)
10.07.17	New Juncker Plan transaction in France: Cellnovo concludes a loan agreement for up to €20 million from the European Investment Bank (Businesswire)
05.07.17	Cellnovo Group: Availability of the 2016 reference document and updated information on the Company’s financing (Businesswire)
26.06.17	Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
20.04.17	Cellnovo Announces that Diabeloop is Launching a CE Marking Registration Study on Artificial Pancreas with Cellnovo Pump (Businesswire)
18.04.17	Cellnovo Acquires Commercial License for Artificial Pancreas Technology from TypeZero Technologies (Businesswire)
16.11.16	Cellnovo Files for 510(k) Approval with the FDA for Its Mobile, Connected, All-in-One Diabetes Management System (Businesswire)
07.11.16	Cellnovo Announces Its 2017 Financial Calendar (Businesswire)
20.10.16	Cellnovo Reports Strong Sales Growth over the First 9 Months of 2016 (Businesswire)
26.09.16	Cellnovo Strengthens Board by Appointing Rémi Soula as a Non-Executive Director (Businesswire)
16.09.16	Cellnovo Raises circa EUR 5.4M in Capital Increase without Preferential Subscription Rights (Businesswire)
07.09.16	Cellnovo: Notice of Half Year Results (Businesswire)
06.09.16	Cellnovo: First Batch of Cellnovo Insulin Cartridges Produced by Flex (Businesswire)
29.07.16	Cellnovo Introduces Manual Blood Glucose Entry Feature for CGM Users (Businesswire)
20.07.16	Cellnovo: 2016 First Half Sales (Businesswire)
23.06.16	New Study Highlights Superior Accuracy of Cellnovo Diabetes Management System Compared to Other Leading Patch Pumps (Businesswire)
09.06.16	Cellnovo Appoints John Brooks as Chairman of the Board of Directors (Businesswire)
27.04.16	Cellnovo Announces Its Full Year 2015 Results and Q1 2016 Sales (Businesswire)
13.04.16	Cellnovo’s Diabetes Management System Selected for Inclusion in EUR 4 Million Diabetes Self-Management Project (Businesswire)
11.04.16	Cellnovo Appoints Sophie Baratte as Interim Chairman of the Board (Businesswire)
15.03.16	Cellnovo and Roche Sign Commercial Blood Glucose Monitor Agreement (Businesswire)
25.02.16	Cellnovo Reaches First Insulin Cartridge Industrialization Milestone (Businesswire)
22.02.16	Cellnovo Appoints Thierry Moulin as Chief Financial Officer (Businesswire)
11.02.16	Cellnovo to Market its Diabetes Management System in Italy (Businesswire)
05.02.16	Cellnovo Partners with US Company TypeZero on Artificial Pancreas Programme (Businesswire)
20.01.16	Cellnovo: 2015 Full Year Sales (Businesswire)
15.01.16	Cellnovo: Half-Yearly Report on the Liquidity Contract With CM-CIC Securities (Businesswire)
15.01.16	Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
10.12.15	Cellnovo Admitted to the SRD Long-Seulement Long-Only Deferred Settlement Service (Businesswire)
09.12.15	Cellnovo’s Diabetes Management System Featured in NHS Alliance Programme ‘Communities of Care’ (Businesswire)
07.12.15	Cellnovo: Appointment of Javaid Masoud as Chief Technology Officer (Businesswire)
16.11.15	Cellnovo presents its unique mobile diabetes management system at Nordic Mobile Health Technology Congress (Businesswire)
22.10.15	Cellnovo Records Strong Sales Growth over the First 9 Months of 2015 (Businesswire)
09.10.15	Cellnovo expands its organisation (Businesswire)
29.09.15	Cellnovo Expands Partnership with Flex as It Begins High-Volume Manufacturing of Its Connected All-in-One Diabetes Management System (Businesswire)
22.09.15	Cellnovo joins the Euronext indexes CAC® Small, CAC® Mid & Small and CAC® All-Tradable and announces its 2015/2016 financial calendar (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Geberit	510.00	3.09 %	K V
UBS Group	29.96	1.97 %	K V
Zurich Insur Gr	537.60	1.55 %	K V
Logitech Intl	80.34	1.47 %	K V
Swiss Life Hldg	717.00	1.36 %	K V
Kuehne+Nagel Int	200.90	0.45 %	K V
Swisscom	509.00	0.30 %	K V
Alcon	75.84	0.18 %	K V
Nestle	73.66	-0.67 %	K V
CieFinRichemont	139.05	-0.82 %	K V

Nachrichten zu Cellnovo Group SA

Aktien Top/Flop

Meistgelesene Nachrichten